Junhemeng Biopharmaceutical Funding: $85M Raised, Series C

Junhemeng Biopharmaceutical funding overview

Junhemeng Biopharmaceutical is based in Hangzhou, China. Junhemeng Biopharmaceutical has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2026. The round record for Junhemeng Biopharmaceutical runs through 2026; nothing later has been disclosed. Investors on record include Heda Venture, Harmony Venture, CS Capital, 3E Bioventures Capital, Guangdian Capital, Hongsheng Junhao Investment and 2 others. 8 distinct backers are named across the disclosed rounds.

Junhemeng Biopharmaceutical at a glance

Total raised: $85M
Latest round: Series C
Latest round date: June 2026
Headquarters: Hangzhou, China
Notable investors: Heda Venture, Harmony Venture, CS Capital, 3E Bioventures Capital, Guangdian Capital, Hongsheng Junhao Investment, Zhongtou Zhongcai Capital, WinX Capital

Frequently asked about Junhemeng Biopharmaceutical funding

How much has Junhemeng Biopharmaceutical raised?: Junhemeng Biopharmaceutical has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Junhemeng Biopharmaceutical?: Heda Venture, Harmony Venture, CS Capital, 3E Bioventures Capital, Guangdian Capital, Hongsheng Junhao Investment are named among the investors backing Junhemeng Biopharmaceutical.
What was the latest Junhemeng Biopharmaceutical funding round?: The most recent disclosed round is a Series C, announced in June 2026.
Where is Junhemeng Biopharmaceutical based?: Junhemeng Biopharmaceutical is based in Hangzhou, China.
When did Junhemeng Biopharmaceutical last raise?: The last disclosed Junhemeng Biopharmaceutical round closed in June 2026 at Series C.

We update the Junhemeng Biopharmaceutical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.

Junhemeng Biopharmaceutical Funding: $85M Raised, Series C

Junhemeng Biopharmaceutical funding overview

Junhemeng Biopharmaceutical at a glance

Frequently asked about Junhemeng Biopharmaceutical funding

Companies related to Junhemeng Biopharmaceutical (18)

Browse related funding lists (4)